Innofactor (IFA1V) Q2 2024 earnings summary

Executive summary

• Q2 2024 net sales were EUR 19.9 million, down 1.1% year-over-year, with H1 2024 net sales up 1.8% to EUR 41.1 million.

• Q2 EBITDA dropped 65.8% to EUR 0.6 million, mainly due to EUR 0.75 million in legal expenses; adjusted EBITDA was EUR 1.4 million.

• Order backlog at period end was EUR 70.4 million, down 8.9% year-over-year but up 2.2% sequentially.

• Market conditions remained challenging, especially in Sweden and Denmark, leading to personnel reductions in Sweden.

• No acquisitions or changes in group structure during the period.

Financial highlights

• Q2 2024 EBITDA: EUR 0.6 million (3.0% margin), down from EUR 1.8 million (8.8%) in Q2 2023; H1 2024 EBITDA: EUR 3.2 million (7.8%), down from EUR 4.3 million (10.5%).

• Q2 2024 EBIT: EUR -0.1 million (-0.7% margin); H1 2024 EBIT: EUR 1.7 million (4.1%), both down year-over-year.

• Q2 2024 net loss: EUR 0.34 million; H1 2024 net income: EUR 1.0 million, down 30.8% year-over-year.

• Operating cash flow for H1 2024 was EUR 5.5 million, up from EUR 3.9 million in H1 2023.

• Equity ratio improved to 51.0% (up from 46.6% a year ago); net gearing reduced to 24.6%.

Outlook and guidance

• Net sales and EBITDA for full year 2024 are expected to increase from 2023 (net sales EUR 80.3 million, EBITDA EUR 9.1 million).

• Management remains focused on long-term targets: 20% annual growth, 20% EBITDA margin, and positive cash flow.

• Improved order backlog and corrective actions, especially in Sweden, are expected to support profitability in H2.